A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection.
Zhao AV, Crutchley RD, Guduru RC, Ton K, Lam T, Min AC.
Zhao AV, et al. Among authors: min ac.
Retrovirology. 2022 Oct 22;19(1):22. doi: 10.1186/s12977-022-00608-1.
Retrovirology. 2022.
PMID: 36273165
Free PMC article.
Review.
The most common adverse events observed in clinical studies involving INSTIs included diarrhea, nausea, insomnia, fatigue, and headache, with very low rates of treatment discontinuation versus comparator groups. The long-term clinical implications of weight gain associated …
The most common adverse events observed in clinical studies involving INSTIs included diarrhea, nausea, insomnia, fatigue, and headache, wit …